Iscalimab (CD40/TNFRSF5) - Research Grade Biosimilar
Product Specifications
Background
Iscalimab (CFZ533) is fully human monoclonal antibody targeting differentiation cluster 40 (CD40), which cy pathway, preventing CD40 pathway signaling and CD40 + cell type activation It has become a new therapy for the treatment of solid organs and related autoimmune diseases.
Immunogen
Homo sapiens / CD40/TNFRSF5 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
CFZ-533, NVP-CFZ533, OM11-62MF
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
